KorrekturOpen Access · CC BY 4.0
Correction to “Clinical Significance of Albumin‐ and Bilirubin‐Based Biomarkers in Glaucoma: A Retrospective Case–Control Study”
Oxidative Medicine and Cellular Longevity · 2026-01 · 2026 (1)
DOI: 10.1155/omcl/9767860 ↗Kurz gefasst
Korrektur in der Zeitschrift Oxidative Medicine and Cellular Longevity, online erschienen am 01.07.2026. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Correction to “Clinical Significance of Albumin‐ and Bilirubin‐Based Biomarkers in Glaucoma: A Retrospective Case–Control Study”. Oxidative Medicine and Cellular Longevity, 2026(1). https://doi.org/10.1155/omcl/9767860
Vancouver
Correction to “Clinical Significance of Albumin‐ and Bilirubin‐Based Biomarkers in Glaucoma: A Retrospective Case–Control Study”. Oxidative Medicine and Cellular Longevity. 2026;2026(1). doi:10.1155/omcl/9767860
BibTeX
@article{euvimed2026,
title = {Correction to “Clinical Significance of Albumin‐ and Bilirubin‐Based Biomarkers in Glaucoma: A Retrospective Case–Control Study”},
journal = {Oxidative Medicine and Cellular Longevity},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/omcl/9767860}
}
EUVIMED